{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:11:06Z","timestamp":1790734266561,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T00:00:00Z","timestamp":1350000000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1038\/eye.2012.199","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T09:45:21Z","timestamp":1350035121000},"page":"1517-1526","source":"Crossref","is-referenced-by-count":112,"title":["Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes"],"prefix":"10.1038","volume":"26","author":[{"given":"D A M","family":"Lyall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Foot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S T D","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Virdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"MacEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,12]]},"reference":[{"key":"BFeye2012199_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archopht.124.4.529","volume":"124","author":"CA Augood","year":"2006","unstructured":"Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006; 124: 529\u2013535.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012199_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2458-6-58","volume":"6","author":"C Bunce","year":"2006","unstructured":"Bunce C, Wormald R . Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58.","journal-title":"BMC Public Health"},{"key":"BFeye2012199_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0161-6420(92)31871-8","volume":"99","author":"R Klein","year":"1992","unstructured":"Klein R, Klein BE, Linton KL . Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933\u2013943.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0161-6420(95)30846-9","volume":"102","author":"P Mitchell","year":"1995","unstructured":"Mitchell P, Smith W, Attebo K, Wang JJ . Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450\u20131460.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0008-4182(05)80070-5","volume":"40","author":"MM Brown","year":"2005","unstructured":"Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR . Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 2005; 40: 277\u2013287.","journal-title":"Can J Ophthalmol"},{"key":"BFeye2012199_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/bjo.87.3.312","volume":"87","author":"CG Owen","year":"2003","unstructured":"Owen CG, Fletcher AE, Donoghue M, Rudnicka AR . How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol 2003; 87: 312\u2013317.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012199_CR7","unstructured":"NICE. . HTA Ranibizumab and Pegaptanib for the treatment of AMD. Final Scope 2006."},{"key":"BFeye2012199_CR8","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1136\/bjo.2010.195370","volume":"95","author":"DC Minassian","year":"2011","unstructured":"Minassian DC, Reidy A, Lightstone A, Desai P . Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy. Br J Ophthalmol 2011; 95: 1433\u20131436.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012199_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432\u20131444.","journal-title":"N Engl J Med"},{"key":"BFeye2012199_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajo.2011.01.053","volume":"152","author":"S Day","year":"2011","unstructured":"Day S, Acquah K, Mruthyunjaya P, Grossman DS, Lee PP, Sloan FA . Ocular complications after anti-vascular endothelial growth factor therapy in medicare patients with age-related macular degeneration. Am J Ophthalmol 2011; 152: 266\u2013272.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012199_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1136\/bjo.2010.180729","volume":"95","author":"TJ Good","year":"2011","unstructured":"Good TJ, Kimura AE, Mandava N, Kahook MY . Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Br J Ophthalmol 2011; 95: 1111\u20131114.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012199_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419\u20131431.","journal-title":"N Engl J Med"},{"key":"BFeye2012199_CR13","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jcrs.2009.05.050","volume":"35","author":"MU Saeed","year":"2009","unstructured":"Saeed MU, Prasad S . Management of cataract caused by inadvertent capsule penetration during intravitreal injection of ranibizumab. J Cataract Refract Surg 2009; 35: 1857\u20131859.","journal-title":"J Cataract Refract Surg"},{"key":"BFeye2012199_CR14","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1097\/IAE.0b013e31820f4b4f","volume":"31","author":"SS Bhatt","year":"2011","unstructured":"Bhatt SS, Stepien KE, Joshi K . Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina 2011; 31: 2032\u20132036.","journal-title":"Retina"},{"key":"BFeye2012199_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.ophtha.2012.02.014","volume":"119","author":"CS Cheung","year":"2012","unstructured":"Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC . Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 2012; 119: 1609\u20131614.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/IAE.0b013e31819d2591","volume":"29","author":"T Diago","year":"2009","unstructured":"Diago T, McCannel CA, Bakri SJ, Pulido JS, Edwards AO, Pach JM . Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina 2009; 29: 601\u2013605.","journal-title":"Retina"},{"key":"BFeye2012199_CR17","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/IAE.0b013e3181884fd2","volume":"28","author":"DR Fintak","year":"2008","unstructured":"Fintak DR, Shah GK, Blinder KJ, Regillo CD, Pollack J, Heier JS et al. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab. Retina 2008; 28: 1395\u20131399.","journal-title":"Retina"},{"key":"BFeye2012199_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000329863","volume":"226","author":"M Inoue","year":"2011","unstructured":"Inoue M, Kobayakawa S, Sotozono C, Komori H, Tanaka K, Suda Y et al. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor. Ophthalmologica 2011; 226: 145\u2013150.","journal-title":"Ophthalmologica"},{"key":"BFeye2012199_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1089\/jop.2006.0146","volume":"23","author":"JB Jonas","year":"2007","unstructured":"Jonas JB, Spandau UH, Rensch F, Von Baltz S, Schlichtenbrede F . Infectious and noninfectious endophthalmitis after intravitreal bevacizumab. J Ocul Pharmacol Ther 2007; 23: 240\u2013242.","journal-title":"J Ocul Pharmacol Ther"},{"key":"BFeye2012199_CR20","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","volume":"31","author":"CA McCannel","year":"2011","unstructured":"McCannel CA . Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011; 31: 654\u2013661.","journal-title":"Retina"},{"key":"BFeye2012199_CR21","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IAE.0b013e31821067c4","volume":"31","author":"AA Moshfeghi","year":"2011","unstructured":"Moshfeghi AA, Rosenfeld PJ, Flynn HW, Schwartz SG, Davis JL, Murray TG et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 2011; 31: 662\u2013668.","journal-title":"Retina"},{"key":"BFeye2012199_CR22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ajo.2007.12.036","volume":"145","author":"S Pilli","year":"2008","unstructured":"Pilli S, Kotsolis A, Spaide RF, Slakter J, Freund KB, Sorenson J et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 2008; 145: 879\u2013882.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2012199_CR23","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1136\/bjo.80.7.592","volume":"80","author":"P Desai","year":"1996","unstructured":"Desai P, MacEwen CJ, Baines P, Minassian DC . Incidence of cases of ocular trauma admitted to hospital and incidence of blinding outcome. Br J Ophthalmol 1996; 80: 592\u2013596.","journal-title":"Br J Ophthalmol"},{"key":"BFeye2012199_CR24","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1167\/iovs.10-5400","volume":"51","author":"D Mitry","year":"2010","unstructured":"Mitry D, Charteris DG, Yorston D, Siddiqui MA, Campbell H, Murphy AL et al. The epidemiology and socioeconomic associations of retinal detachment in Scotland: a two-year prospective population-based study. Invest Ophthalmol Vis Sci 2010; 51: 4963\u20134968.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2012199_CR25","unstructured":"Key population and vital statistics No.34, 2007 ed. Released 24 April 2009. Office for National Statistics (\n                    www.ons.gov.uk\n                    \n                  )."},{"key":"BFeye2012199_CR26","unstructured":"R Development Core Team. R: A language and environment for statistical computing. R Foundation for statistical computing: Vienna, Austria, 2011."},{"key":"BFeye2012199_CR27","doi-asserted-by":"crossref","unstructured":"Zamar D, McNeney B, Graham J . elrm: software implementing exact-like inference for logistic regression models. J Stat Softw 2007; 21.","DOI":"10.18637\/jss.v021.i03"},{"key":"BFeye2012199_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj.eye.6700645","volume":"18","author":"S Kamalarajah","year":"2004","unstructured":"Kamalarajah S, Silvestri G, Sharma N, Khan A, Foot B, Ling R et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye (Lond) 2004; 18: 580\u2013587.","journal-title":"Eye (Lond)"},{"key":"BFeye2012199_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/157488410790410597","volume":"5","author":"C Lopez-Cabezas","year":"2010","unstructured":"Lopez-Cabezas C, Muner DS, Massa MR, Mensa Pueyo JM . Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations. Curr Clin Pharmacol 2010; 5: 47\u201354.","journal-title":"Curr Clin Pharmacol"},{"key":"BFeye2012199_CR30","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.ophtha.2005.01.050","volume":"112","author":"JQ Ng","year":"2005","unstructured":"Ng JQ, Morlet N, Pearman JW, Constable IJ, McAllister IL, Kennedy CJ et al. Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: the Endophthalmitis Population Study of Western Australia (EPSWA)\u2019s fifth report. Ophthalmology 2005; 112: 1199\u20131206.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR31","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcrs.2011.06.018","volume":"37","author":"M Packer","year":"2011","unstructured":"Packer M, Chang DF, Dewey SH, Little BC, Mamalis N, Oetting TA et al. Prevention, diagnosis, and management of acute postoperative bacterial endophthalmitis. J Cataract Refract Surg 2011; 37: 1699\u20131714.","journal-title":"J Cataract Refract Surg"},{"key":"BFeye2012199_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archophthalmol.2010.202","volume":"128","author":"DR Almeida","year":"2010","unstructured":"Almeida DR, Miller D, Alfonso EC . Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis. Arch Ophthalmol 2010; 128: 1136\u20131139.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012199_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrs.2006.10.022","volume":"33","author":"SP Mollan","year":"2007","unstructured":"Mollan SP, Gao A, Lockwood A, Durrani OM, Butler L . Postcataract endophthalmitis: incidence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg 2007; 33: 265\u2013268.","journal-title":"J Cataract Refract Surg"},{"key":"BFeye2012199_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/MCC.0b013e32834c9d87","volume":"17","author":"PJ van Duijn","year":"2011","unstructured":"van Duijn PJ, Dautzenberg MJ, Oostdijk EA . Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care 2011; 17: 658\u2013665.","journal-title":"Curr Opin Crit Care"},{"key":"BFeye2012199_CR35","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/archopht.1997.01100160312008","volume":"115","author":"M Barza","year":"1997","unstructured":"Barza M, Pavan PR, Doft BH, Wisniewski SR, Wilson LA, Han DP et al. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1997; 115: 1142\u20131150.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012199_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00417-011-1851-1","volume":"250","author":"C Irigoyen","year":"2012","unstructured":"Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H . Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol 2012; 250: 499\u2013505.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2012199_CR37","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jcrs.2011.06.019","volume":"37","author":"Y Sheng","year":"2011","unstructured":"Sheng Y, Sun W, Gu Y, Lou J, Liu W . Endophthalmitis after cataract surgery in China, 1995-2009. J Cataract Refract Surg 2011; 37: 1715\u20131722.","journal-title":"J Cataract Refract Surg"},{"key":"BFeye2012199_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj.eye.6702368","volume":"21","author":"S Kamalarajah","year":"2007","unstructured":"Kamalarajah S, Ling R, Silvestri G, Sharma NK, Cole MD, Cran G et al. Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye (Lond) 2007; 21: 580\u2013586.","journal-title":"Eye (Lond)"},{"key":"BFeye2012199_CR39","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ophtha.2006.11.025","volume":"114","author":"M Lundstrom","year":"2007","unstructured":"Lundstrom M, Wejde G, Stenevi U, Thorburn W, Montan P . Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology 2007; 114: 866\u2013870.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/S0161-6420(98)91211-8","volume":"105","author":"PG Montan","year":"1998","unstructured":"Montan PG, Koranyi G, Setterquist HE, Stridh A, Philipson BT, Wiklund K . Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history: a retrospective case-control study. Ophthalmology 1998; 105: 2171\u20132177.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/IAE.0b013e3181633fee","volume":"28","author":"JO Mason","year":"2008","unstructured":"Mason JO, White MF, Feist RM, Thomley ML, Albert MA, Persaud TO et al. Incidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injection. Retina 2008; 28: 564\u2013567.","journal-title":"Retina"},{"key":"BFeye2012199_CR42","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","volume":"118","author":"CP Shah","year":"2011","unstructured":"Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA . Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 2011; 118: 2028\u20132034.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0886-3350(02)01503-1","volume":"29","author":"AK Aralikatti","year":"2003","unstructured":"Aralikatti AK, Needham AD, Lee MW, Prasad S . Entry of antibiotic ointment into the anterior chamber after uneventful phacoemulsification. J Cataract Refract Surg 2003; 29: 595\u2013597.","journal-title":"J Cataract Refract Surg"},{"key":"BFeye2012199_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jcrs.2005.12.093","volume":"32","author":"L Werner","year":"2006","unstructured":"Werner L, Sher JH, Taylor JR, Mamalis N, Nash WA, Csordas JE et al. Toxic anterior segment syndrome and possible association with ointment in the anterior chamber following cataract surgery. J Cataract Refract Surg 2006; 32: 227\u2013235.","journal-title":"J Cataract Refract Surg"},{"key":"BFeye2012199_CR45","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0161-6420(99)90546-8","volume":"106","author":"AJ Aldave","year":"1999","unstructured":"Aldave AJ, Stein JD, Deramo VA, Shah GK, Fischer DH, Maguire JI . Treatment strategies for postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999; 106: 2395\u20132401.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR46","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0161-6420(99)90348-2","volume":"106","author":"WL Clark","year":"1999","unstructured":"Clark WL, Kaiser PK, Flynn HW, Belfort A, Miller D, Meisler DM . Treatment strategies and visual acuity outcomes in chronic postoperative Propionibacterium acnes endophthalmitis. Ophthalmology 1999; 106: 1665\u20131670.","journal-title":"Ophthalmology"},{"key":"BFeye2012199_CR47","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"The Endophthalmitis Study Group","year":"1995","unstructured":"The Endophthalmitis Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995; 113: 1479\u20131496.","journal-title":"Arch Ophthalmol"},{"key":"BFeye2012199_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.eye.6700233","volume":"17","author":"B Foot","year":"2003","unstructured":"Foot B, Stanford M, Rahi J, Thompson J . The British Ophthalmological Surveillance Unit: an evaluation of the first 3 years. Eye (Lond) 2003; 17: 9\u201315.","journal-title":"Eye (Lond)"},{"key":"BFeye2012199_CR49","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/eye.2011.89","volume":"25","author":"SP Kelly","year":"2011","unstructured":"Kelly SP, Barua A . A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications. Eye (Lond) 2011; 25: 710\u2013716.","journal-title":"Eye (Lond)"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2012199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012199","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2012199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:07Z","timestamp":1684430227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2012199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["BFeye2012199"],"URL":"https:\/\/doi.org\/10.1038\/eye.2012.199","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,12]]}}}